Closed-loop minimal sampling method for determining viral-load minima during switching
暂无分享,去创建一个
[1] Dominik Wodarz,et al. Treatment interruptions to decrease risk of resistance emerging during therapy switching in HIV treatment , 2007, 2007 46th IEEE Conference on Decision and Control.
[2] S Bonhoeffer,et al. Production of resistant HIV mutants during antiretroviral therapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[3] A. Telenti,et al. HIV treatment failure: testing for HIV resistance in clinical practice. , 1998, Science.
[4] Michael J. Piovoso,et al. A generalized multi-strain model of HIV evolution with implications for drug-resistance management , 2009, 2009 American Control Conference.
[5] Ryan Zurakowski,et al. Resistance Risk Management in HIV Therapy Switching with Explicit Quiescent T-Cell Modeling , 2008 .
[6] R. Zurakowski,et al. A new strategy to decrease risk of resistance emerging during therapy switching in HIV treatment , 2008, 2008 American Control Conference.